Login / Signup

Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma.

Zongyi YangJia FengLi XiaoXi ChenYuanfei YaoYiqun LiYu TangShuai ZhangMin LuYu QianHongjin WuMing Shi
Published in: Hepatology (Baltimore, Md.) (2020)
We provide evidence that tumor-derived PGLYRP2 acts as a candidate biomarker for adequate immune response against HCC and improved patient outcomes, indicating the importance of hepatic PGLYRP2 in cancer immunosurveillance and in designing immunotherapeutic approaches.
Keyphrases
  • immune response
  • papillary thyroid
  • dendritic cells
  • toll like receptor
  • squamous cell
  • protein protein
  • young adults
  • binding protein